QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection-Reference-Cited by-同舟云学术

QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection

Published:2020-07-20 Issue:5 Volume:108 Page:1090-1097
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Bun Sok‐Sithikun¹,Taghji Philippe²,Courjon Johan³,Squara Fabien¹,Scarlatti Didier¹,Theodore Guillaume¹,Baudouy Delphine¹,Sartre Benjamin¹,Labbaoui Mohamed¹,Dellamonica Jean⁴,Doyen Denis⁴,Marquette Charles‐Hugo⁵,Levraut Jacques⁶,Esnault Vincent⁷,Bun Sok‐Siya⁸⁹,Ferrari Emile¹

Affiliation:

1. Cardiology Department Pasteur University Hospital Nice France

2. Cardiology Department Clinique la Casamance Aubagne France

3. Infectious Diseases Department Archet University Hospital Nice France

4. Medical Intensive Care Unit Archet University Hospital Nice France

5. Department of Respiratory Medicine Pasteur University Hospital Nice France

6. Department of Emergency Medicine Pasteur University Hospital Nice France

7. Nephrology Department Pasteur University Hospital Nice France

8. Pharmacy Faculty CNRS IRD IMBE Aix Marseille University Marseille France

9. Pharmacy Department CHU Nord APHM Marseille France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1968

Reference34 articles.

1. Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial;Gautret P.;Int. J. Antimicrob. Agents,2020

2. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID‐ 19: a multinational registry analysis;Mehra M.R.;Lancet,2020

3. Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine;O’Laughlin J.P.;Case Rep. Cardiol.,2016

4. Azithromycin-Induced Proarrhythmia and Cardiovascular Death

5. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19;Irish Journal of Medical Science (1971 -);2023-07-29

2. The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread;Immunity, Inflammation and Disease;2023-03

3. Prevalence and Clinical Characteristics of Patients with Torsades de Pointes Complicating Acquired Atrioventricular Block;Journal of Clinical Medicine;2023-01-30

4. Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine—a possible prevention strategy for COVID-19?;Molecular and Cellular Biochemistry;2022-08-29

5. Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers;Clinical Pharmacology & Therapeutics;2022-06-22